Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings: the ETHOS III Study

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/2006282

Funding Status
Status not available

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Progress towards hepatitis C elimination has been slowed. Given that most people with hepatitis C have a history of injecting drug use, reducing hepatitis C burden requires scale-up of enhanced testing and treatment for people who inject drugs. This Partnership project will evaluate an intervention to enhance hepatitis C testing and treatment in drug treatment clinics and develop a translational framework to scale-up hepatitis C care in this setting nationally.

Funded Activity Details

Start Date: 01-01-2022

End Date: 01-01-2027

Funding Scheme: Partnership Projects

Funding Amount: $1,349,604.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

health policy | injecting drug use | liver disease | treatment strategies

Related Links